Comprehensive metabolic profiling of Parkinson's disease by liquid chromatography-mass spectrometry.

Yaping ShaoTianbai LiZheyi LiuXiaolin WangXiaojiao XuSong LiGuowang XuWei-Dong Le

Published in: Molecular neurodegeneration (2021)

This study may help improve our understanding of PD etiopathogenesis and facilitate target screening for therapeutic intervention. The metabolite panel identified in this study may provide novel approach for the clinical diagnosis of PD in the future.

Keyphrases

mass spectrometry
liquid chromatography
randomized controlled trial
single cell
high resolution mass spectrometry
simultaneous determination